gadofosveset trisodium has been researched along with Cancer of Pancreas in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheung, HM; Coburn, N; Karanicolas, PJ; Law, C; Milot, L; Shoichet, M | 1 |
| Daducci, A; Degrassi, A; Farace, P; Fiorini, S; Marzola, P; Merigo, F; Nicolato, E; Rubello, D; Sbarbati, A; Tambalo, S | 1 |
1 review(s) available for gadofosveset trisodium and Cancer of Pancreas
| Article | Year |
|---|---|
Appearance of Focal Liver Lesions Using Contrast-Enhanced Magnetic Resonance Imaging Using Gadofosveset Trisodium, an Intravascular (Blood-Pool) Contrast Agent: A Pictorial Essay.
Topics: Adenocarcinoma; Adenoma; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Cholangiocarcinoma; Colorectal Neoplasms; Contrast Media; Gadolinium; Hemangioma; Humans; Hyperplasia; Kidney Neoplasms; Liver Neoplasms; Magnetic Resonance Imaging; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms | 2016 |
1 other study(ies) available for gadofosveset trisodium and Cancer of Pancreas
| Article | Year |
|---|---|
DCE-MRI using small-molecular and albumin-binding contrast agents in experimental carcinomas with different stromal content.
Topics: Animals; Cell Line, Tumor; Contrast Media; Gadolinium; Gadolinium DTPA; Image Enhancement; Image Interpretation, Computer-Assisted; Immunoenzyme Techniques; Magnetic Resonance Imaging; Male; Mice; Mice, Nude; Neoplasms, Experimental; Organometallic Compounds; Pancreatic Neoplasms; Prostatic Neoplasms | 2011 |